Literature DB >> 10337363

Very low-intensity antithrombotic therapy in atrial fibrillation.

B G Koefoed1, P Petersen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10337363     DOI: 10.1023/a:1008835505438

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  30 in total

1.  Effects of fixed minidose warfarin on coagulation and fibrinolysis following major gynaecological surgery.

Authors:  P K MacCallum; J M Thomson; L Poller
Journal:  Thromb Haemost       Date:  1990-12-28       Impact factor: 5.249

2.  Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.

Authors:  B G Koefoed; C Feddersen; A L Gulløv; P Petersen
Journal:  Thromb Haemost       Date:  1997-05       Impact factor: 5.249

Review 3.  Low-dose warfarin and low-dose aspirin in the primary prevention of ischemic heart disease.

Authors:  T W Meade
Journal:  Am J Cardiol       Date:  1990-02-02       Impact factor: 2.778

4.  Nonvalvular atrial fibrillation as a cause of fatal massive cerebral infarction in the elderly.

Authors:  H Yamanouchi; M Tomonaga; H Shimada; S Matsushita; K Kuramoto; Y Toyokura
Journal:  Stroke       Date:  1989-12       Impact factor: 7.914

5.  Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Authors:  P Petersen; G Boysen; J Godtfredsen; E D Andersen; B Andersen
Journal:  Lancet       Date:  1989-01-28       Impact factor: 79.321

6.  Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulant Therapy Study (AFASAK 2): Methods and Design.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

7.  Non-rheumatic atrial fibrillation as a risk factor for stroke.

Authors:  M Britton; C Gustafsson
Journal:  Stroke       Date:  1985 Mar-Apr       Impact factor: 7.914

8.  Stroke severity in atrial fibrillation. The Framingham Study.

Authors:  H J Lin; P A Wolf; M Kelly-Hayes; A S Beiser; C S Kase; E J Benjamin; R B D'Agostino
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

9.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.

Authors:  S J Connolly; A Laupacis; M Gent; R S Roberts; J A Cairns; C Joyner
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

10.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.